189.70M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Inventiva S. A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH.

Similar securities

Based on sector and market capitalization

Report issue